1. Home
  2. CKPT vs TITN Comparison

CKPT vs TITN Comparison

Compare CKPT & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • TITN
  • Stock Information
  • Founded
  • CKPT 2014
  • TITN 1980
  • Country
  • CKPT United States
  • TITN United States
  • Employees
  • CKPT N/A
  • TITN N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • TITN Other Specialty Stores
  • Sector
  • CKPT Health Care
  • TITN Consumer Discretionary
  • Exchange
  • CKPT Nasdaq
  • TITN Nasdaq
  • Market Cap
  • CKPT 361.1M
  • TITN 341.6M
  • IPO Year
  • CKPT 2017
  • TITN 2007
  • Fundamental
  • Price
  • CKPT $4.26
  • TITN $18.68
  • Analyst Decision
  • CKPT Buy
  • TITN Buy
  • Analyst Count
  • CKPT 3
  • TITN 5
  • Target Price
  • CKPT $4.33
  • TITN $21.00
  • AVG Volume (30 Days)
  • CKPT 2.1M
  • TITN 251.5K
  • Earning Date
  • CKPT 05-13-2025
  • TITN 05-22-2025
  • Dividend Yield
  • CKPT N/A
  • TITN N/A
  • EPS Growth
  • CKPT N/A
  • TITN N/A
  • EPS
  • CKPT N/A
  • TITN N/A
  • Revenue
  • CKPT $41,000.00
  • TITN $2,667,755,000.00
  • Revenue This Year
  • CKPT $102,182.93
  • TITN N/A
  • Revenue Next Year
  • CKPT $351.71
  • TITN $3.22
  • P/E Ratio
  • CKPT N/A
  • TITN N/A
  • Revenue Growth
  • CKPT N/A
  • TITN N/A
  • 52 Week Low
  • CKPT $1.80
  • TITN $12.30
  • 52 Week High
  • CKPT $4.50
  • TITN $23.41
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 80.26
  • TITN 46.67
  • Support Level
  • CKPT $4.14
  • TITN $19.26
  • Resistance Level
  • CKPT $4.20
  • TITN $20.68
  • Average True Range (ATR)
  • CKPT 0.03
  • TITN 1.13
  • MACD
  • CKPT -0.00
  • TITN -0.25
  • Stochastic Oscillator
  • CKPT 85.71
  • TITN 0.63

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: